StockData
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc. (AMLX) income statement

AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$26.02−0.18 (-0.69%)

Close on Nov 20, 2026Market cap $2.90BP/E –Yield –

Amylyx Pharmaceuticals, Inc. financial ratios

See a number that looks wrong?